UNSPSC 51294508: Litoxetine

This classification denotes an antidepressant agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 9980ST005G. European Medicines Agency schedules Litoxetine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08536MIG. Litoxetine generally arises in the molecular formula C16H19NO. The term LITOXETINE is an International Non-Proprietary Name or INN. LITOXETINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix.

Most nations schedule litoxetine under HS 29333999 and SITC 51574. As of Q4 2014, LITOXETINE remains the US FDA Preferred Term for this commodity. Litoxetine bears US NLM identifiers UMLS ID C0165077 and NCI Concept Code C66021. SMILES: O(C1CCNCC1)Cc1cc2c(cc1)cccc2.

UNSPSC 51294508 Litoxetine is a Commodity code that captures pharmaceutical products and related medical supplies procured by state and local health agencies, though recent state and local solicitation activity under this specific code appears limited. The single identified recent opportunity — Seminole County, Florida's IFB 60459723LAS — involved procurement of naloxone and safe drug deactivation systems rather than litoxetine itself, suggesting either a coding mismatch in the state and local opportunity database or minimal recent activity directly under this commodity designation. State and local buying under pharmaceutical codes typically flows through county health departments, city public health offices, and emergency services agencies seeking to stock medications and medical countermeasures for community health initiatives, overdose response, and emergency preparedness. Procurement vehicles for pharmaceuticals often require compliance with federal funding streams (such as FEMA), drug-free workplace certification, E-Verify verification, and standard insurance and bonding requirements.

Seminole County, Florida posted the only recent opportunity visible in the source block, an IFB with a response deadline of July 26, 2023 (now past), seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford. The contract was structured as a two-year initial term with a one-year renewal option, included FEMA compliance requirements, and did not carry explicit set-aside designations. The mismatch between the code name (litoxetine, a selective serotonin reuptake inhibitor) and the actual goods solicited (naloxone and drug deactivation systems) signals that either the opportunity was miscoded or the code itself sees minimal relevant state and local procurement activity. Business development activity under this code should confirm whether current market demand aligns with the commodity's pharmaceutical classification or track alternative codes capturing overdose-response and emergency-health-supply procurement more actively.